JFNAX

Janus Henderson Global Life Sciences Fund Class A [JFNAX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

JFNAX Stock Summary

Top 10 Correlated ETFs

JFNAX

Top 10 Correlated Stocks

JFNAX

In the News

JFNAX Financial details

Company Rating
-
Market Cap
5.28B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.02
Dividend %
0.02%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-3.13%
SMA50
-8.82%
SMA100
-7.46%
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
60.56-73.81
52W High
-15.1%
52W Low
+3.3%
RSI
45
Rel Volume
-
Avg Volume
-
Volume
Perf Week
0.63%
Perf Month
-1.37%
Perf Quarter
-17.9%
Perf Half Y
-16.96%
-
-
-
-
Beta
0.73
-
-
Volatility
0.6%, 1.5%
Prev Close
-0.13%
Price
61.98
Change
-0.13%

JFNAX Financial Performance

JFNAX Dividend History

JFNAX Frequently Asked Questions

What is Janus Henderson Global Life Sciences Fund Class A stock symbol ?

Janus Henderson Global Life Sciences Fund Class A is a US stock and trading under the symbol JFNAX

What is Janus Henderson Global Life Sciences Fund Class A stock quote today ?

Janus Henderson Global Life Sciences Fund Class A stock price is $61.98 today.

Is Janus Henderson Global Life Sciences Fund Class A stock public?

Yes, Janus Henderson Global Life Sciences Fund Class A is a publicly traded company.

Something similar

Top by Market Cap
LLY
FB2A.DE
MIX.JO
GOOG
VTSAX
Top Correlated ETFs
IXJ
MEDI
VHT
FHLC
PTH
Top Correlated Stocks
SHSCX
SHSKX
SHSSX
SHISX
BHSRX
Similar Market Cap
GALE.SW
GIOAX
IGAF.TO
6104.TWO
600479.SS

Company Profile

Financial Services Asset Management - Global
  • Market Capitalization 5.28B
  • Headquarters US
  • IPO Date 2009-07-06

The investment seeks long-term growth of capital. The fund pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that the portfolio managers believe have a life science orientation. In the fund's pursuit of companies with a life science orientation, the fund has a fundamental policy to normally invest at least 25% of its total assets in securities of companies that are categorized in the "life sciences" sector.